Top news of the week: 24.02.2023.
First Gene Therapy for Hemophilia B, CSL’s HEMGENIX®, Approved by the European Commission
Global biotechnology leader CSL (ASX: CSL) today announced that the European Commission has granted conditional marketing authorization (CMA) for HEMGENIX® (etranacogene dezaparvovec), the ...
Cleara Biotech Appoints Nicholas J. Sarlis, MD, PhD as Chief Medicatl Officer and Head of Clinical Development
CLEARA Biotech Appoints Nicholas J. Sarlis, MD, PhD as Chief Medical Officer and Head of Clinical Development Utrecht, The Netherlands – Feb. 22, 2023 – CLEARA Biotech B.V. ...
AMGEN ANNOUNCES CARDIOVASCULAR STUDY TO EVALUATE ASSOCIATION BETWEEN LIPOPROTEIN(a) AND CARDIOVASCULAR RISK IN AFRICAN AMERICANS
Unique Community-Based Partnership With the Association of Black Cardiologists and Morehouse School of Medicine to Identify Study Sites and Participants Observational Study to …
Thompson Street Capital Partners Completes Growth Investment in OpenClinica
ST. LOUIS--(BUSINESS WIRE)--Thompson Street Capital Partners (TSCP), a private equity firm based in St. Louis, announced today a growth investment in OpenClinica, a cloud-first, unified ...
Phastar Take Lead on Making Sense of Visual Data Analytics at ACDM23 Barcelona
Phastar Take Lead on Making Sense of Visual Data Analytics at ACDM23 Barcelona Specialist biometrics CRO are key sponsor and presenter at industry event to support continuous ...
FDA approves Apellis' retinal disease drug as competitor expects August decision
The FDA approved Apellis Pharmaceuticals' drug for geographic atrophy secondary to age-related macular degeneration after pushing back the green light decision by three months to go through ...
Leena Gandhi leaves Dana-Farber for checkpoint inhibitor biotech
Immuno-oncology pioneer Leena Gandhi is on the move once again. Gandhi is departing the Dana-Farber Institute to become chief medical officer at NextPoint Therapeutics, a private ...
Updated: Resilience to cut most staff, suspend operations at Massachusetts manufacturing plant
National Resilience, a biotech manufacturing startup funded with more than $2 billion since its launch in July 2020, has sent notices to employees that it will cut jobs at a Massachusetts ...